CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 48.60% | -0.16% | — | |
| 2 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 18.94% | — | — | |
| 3 | AKRO | Akero Therapeutics INC | Stock-Other | 15.91% | — | — | |
| 4 | VCYT | Veracyte INC | Stock-Other | 8.04% | — | — | |
| 5 | 2JQ | Gritstone Bio INC | Stock-Other | 4.95% | — | — | |
| 6 | OCUL | Ocular Therapeutix INC | Stock-Other | 3.01% | — | — | |
| 7 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 0.22% | — | — | |
| 8 | CLVSEUR | Clovis Oncology INC | Stock-Other | 0.18% | — | — | |
| 9 | ✓ | Second Sight Med Prods INC | Stock-Other | 0.15% | — | -87.50% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | OCUL | Ocular Therapeutix INC | +0.4% | — | Unchanged |
| 2 | CBAYUSD | Cymabay Therapeutics INC | -0.1% | — | Unchanged |
| 3 | CLVSEUR | Clovis Oncology INC | -0.1% | — | Unchanged |
| 4 | ✓ | Second Sight Med Prods INC | -0.9% | -87.50% | Trim |
| 5 | VCYT | Veracyte INC | -2.1% | — | Unchanged |
| 6 | 2JQ | Gritstone Bio INC | -3.4% | — | Unchanged |
| 7 | CRSP | CRISPR Therapeutics AG | -28.6% | — | Unchanged |
| 8 | ADVMCHF | Adverum Biotechnologies INC | — | NEW | New buy |
| 9 | AKRO | Akero Therapeutics INC | — | NEW | New buy |